Cam P. Pham

Hanoi, Viet Nam

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Real-World Outcomes of SIB-Based Concurrent Chemoradiation Therapy for Upper-Third Esophageal Cancer: A Single-Center Retrospective Study in Vietnam.

Real-World Outcomes of SIB-Based Concurrent Chemoradiation Therapy for Upper-Third Esophageal Cancer: A Single-Center Retrospective Study in Vietnam.

Journal: La Clinica terapeutica

Published: April 28, 2026

First-Line Pembrolizumab Monotherapy for Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Study from Vietnam.

First-Line Pembrolizumab Monotherapy for Advanced Non-Small Cell Lung Cancer: A Multicenter Real-World Study from Vietnam.

Journal: Current oncology (Toronto, Ont.)

Published: February 24, 2026

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Correction: Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology

Published: February 10, 2026

Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE Study.

Treatment Patterns in Early Stage NSCLC in Asia: Findings From the ELEVATE Study.

Journal: JTO clinical and research reports

Published: October 06, 2025

Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam.

Excellent survival benefit achieved in patients with advanced-stage non-small cell lung cancer harboring the epidermal growth factor receptor-G719X mutation treated by afatinib: the real-world data from a multicenter study in Vietnam.

Journal: Therapeutic advances in respiratory disease

Published: May 25, 2025

Prognostic value of survival in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors: Value of SUVmax or value of other factor?

Prognostic value of survival in patients with advanced non-small cell lung cancer treated with tyrosine-kinase inhibitors: Value of SUVmax or value of other factor?

Journal: La Clinica terapeutica

Published: February 17, 2025

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management.

Journal: Frontiers in oncology

Published: October 08, 2024

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment.

Journal: Frontiers in oncology

Published: October 08, 2024

Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment.

Hepatocellular Carcinoma in Asia: Physician and Patient Perspectives on Surveillance, Diagnosis, and Treatment.

Journal: Journal of gastrointestinal cancer

Published: July 05, 2024

First-line atezolizumab monotherapy vs . single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation.

First-line atezolizumab monotherapy vs . single-agent chemotherapy in patients with advanced or metastatic non-small cell lung cancer who are ineligible for platinum-based therapy: Analysis of the IPSOS Asian subpopulation.

Journal: Chinese medical journal

Published: January 25, 2024

BM-BronchoLC - A rich bronchoscopy dataset for anatomical landmarks and lung cancer lesion recognition.

BM-BronchoLC - A rich bronchoscopy dataset for anatomical landmarks and lung cancer lesion recognition.

Journal: Scientific data

Published: November 02, 2023

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam.

A real-world cohort study of first-line afatinib in patients with EGFR-mutant advanced non-small cell lung cancer in Vietnam.

Journal: BMC cancer

Published: September 29, 2023

Showing 1-12 of 17

Last Updated: 09/26/2026